Open-Label Duloxetine Monotherapy in the Treatment of Posttraumatic Stress Disorder

NCT00583193 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

20

Enrollment

INDIV

Sponsor class

Conditions

Posttraumatic Stress Disorders

Interventions

DRUG: Duloxetine hydrochloride

Sponsor

Canive, Jose M., M.D.

Collaborators

[object Object]